Cargando…
Perspectives of Differentiation Therapies of Acute Myeloid Leukemia: The Search for the Molecular Basis of Patients’ Variable Responses to 1,25-Dihydroxyvitamin D and Vitamin D Analogs
The concept of differentiation therapy of cancer is ~40 years old. Despite many encouraging results obtained in laboratories, both in vitro and in vivo studies, the only really successful clinical application of differentiation therapy was all-trans-retinoic acid (ATRA)-based therapy of acute promye...
Autores principales: | Marchwicka, Aleksandra, Cebrat, Małgorzata, Sampath, Preetha, Śnieżewski, Łukasz, Marcinkowska, Ewa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4034350/ https://www.ncbi.nlm.nih.gov/pubmed/24904835 http://dx.doi.org/10.3389/fonc.2014.00125 |
Ejemplares similares
-
Diverse Regulation of Vitamin D Receptor Gene Expression by 1,25-Dihydroxyvitamin D and ATRA in Murine and Human Blood Cells at Early Stages of Their Differentiation
por: Janik, Sylwia, et al.
Publicado: (2017) -
Restored expression of vitamin D receptor and sensitivity to 1,25-dihydroxyvitamin D(3) in response to disrupted fusion FOP2–FGFR1 gene in acute myeloid leukemia cells
por: Marchwicka, Aleksandra, et al.
Publicado: (2016) -
NADPH-Cytochrome P450 Reductase Is Regulated by All-Trans Retinoic Acid and by 1,25-Dihydroxyvitamin D(3) in Human Acute Myeloid Leukemia Cells
por: Gocek, Elżbieta, et al.
Publicado: (2014) -
Immuno-Stimulating Activity of 1,25-Dihydroxyvitamin D in Blood Cells from Five Healthy People and in Blasts from Five Patients with Leukemias and Pre-Leukemic States
por: Marchwicka, Aleksandra, et al.
Publicado: (2023) -
Regulation of Expression of CEBP Genes by Variably Expressed Vitamin D Receptor and Retinoic Acid Receptor α in Human Acute Myeloid Leukemia Cell Lines
por: Marchwicka, Aleksandra, et al.
Publicado: (2018)